Patents by Inventor Brian Mullikin

Brian Mullikin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7390487
    Abstract: Disclosed are chimeric HPV L1 proteins and virus like particles comprising the same which are capable of generating high titer neutralizing antibody responses against at least two HPV types. The disclosed chimeric HPV L1 proteins and VLPs are useful as therapeutic and prophylactic reagents, as well as reagents for diagnosing papillomavirus infection.
    Type: Grant
    Filed: June 16, 2005
    Date of Patent: June 24, 2008
    Assignee: Med Immune, Inc.
    Inventors: Susan D. Wilson, Wendy White, JoAnn Suzich, Brian Mullikin
  • Publication number: 20060127979
    Abstract: Disclosed are chimeric HPV L1 proteins and virus like particles comprising the same which are capable of generating high titer neutralizing antibody responses against at least two HPV types. The disclosed chimeric HPV L1 proteins and VLPs are useful as therapeutic and prophylactic reagents, as well as reagents for diagnosing papillomavirus infection.
    Type: Application
    Filed: June 16, 2005
    Publication date: June 15, 2006
    Inventors: Susan Wilson, Wendy White, JoAnn Suzich, Brian Mullikin
  • Patent number: 6908613
    Abstract: Disclosed are chimeric HPV L1 proteins and virus like particles comprising the same which are capable of generating high titer neutralizing antibody responses against at least two HPV types. The disclosed chimeric HPV L1 proteins and VLPs are useful as therapeutic and prophylactic reagents, as well as reagents for diagnosing papillomavirus infection.
    Type: Grant
    Filed: June 8, 2001
    Date of Patent: June 21, 2005
    Assignee: MedImmune, Inc.
    Inventors: Susan D. Wilson, Wendy White, JoAnn Suzich, Brian Mullikin
  • Publication number: 20040224305
    Abstract: Disclosed are chimeric HPV L1 proteins and virus like particles comprising the same which are capable of generating high titer neutralizing antibody responses against at least two HPV types. The disclosed chimeric HPV L1 proteins and VLPs are useful as therapeutic and prophylactic reagents, as well as reagents for diagnosing papillomavirus infection.
    Type: Application
    Filed: June 8, 2001
    Publication date: November 11, 2004
    Inventors: Susan D. Wilson, Wendy White, JoAnn Suzich, Brian Mullikin